The data showed that approximately 78% of patients were taking drugs belonging to the class of biguanides, 7% GLP-1 agonists, and the remaining 15% were in pharmacological therapy with insulin, alone or in combination, for the treatment of type 1 diabetes. Here, INS is linked to type 1 diabetes mellitus.